Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML
文摘

The GFI136N variant accelerates development of acute myeloid leukemia in acute myeloid leukemia/myelodysplastic syndrome mouse models.

GFI136N induces genomewide epigenetic changes in murine and human acute myeloid leukemia.

GFI36N human and murine leukemic cells respond specifically to histone acetyltransferase inhibitor treatment in vitro.

Use of histone acetyltransferase inhibitor prolongs survival of mice transplanted with GFI136N-expressing leukemia.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.